钙激活氯通道(calcium-activated chloride channels,CaCCs)是一类在多种细胞中广泛表达的氯离子通道,介导一系列重要的生理功能。TMEM16A(transmembrane protein 16A)于2008年被确认为CaCCs的分子身份之一。TMEM16A在多种病理生理过程...钙激活氯通道(calcium-activated chloride channels,CaCCs)是一类在多种细胞中广泛表达的氯离子通道,介导一系列重要的生理功能。TMEM16A(transmembrane protein 16A)于2008年被确认为CaCCs的分子身份之一。TMEM16A在多种病理生理过程中发挥重要的作用,如卵母细胞多重受精、分泌上皮细胞的液体分泌、平滑肌收缩、神经元兴奋、膜电位调节、感官信号传导以及肿瘤的发生和细胞迁移。近年来,TMEM16A在病理生理学中的作用及其在疾病治疗中的药靶地位受到高度重视。本文对TMEM16A研究的最新进展进行综述。展开更多
跨膜蛋白16A(transmembrane protein 16A,TMEM16A)是一种钙激活的氯离子通道(calcium-activated chloride channel,CaCC),它在肿瘤中广泛过表达,对肿瘤的发生发展有着重要的影响。在各种肿瘤中,TMEM16A的过表达不仅可以促进癌细胞的增...跨膜蛋白16A(transmembrane protein 16A,TMEM16A)是一种钙激活的氯离子通道(calcium-activated chloride channel,CaCC),它在肿瘤中广泛过表达,对肿瘤的发生发展有着重要的影响。在各种肿瘤中,TMEM16A的过表达不仅可以促进癌细胞的增殖、转移和侵袭,抑制肿瘤细胞的凋亡,影响肿瘤的生长,还与肿瘤的治疗耐药、复发和预后不良有关。因此,探索TMEM16A的体内表达情况与肿瘤各个方面的关系具有重要的意义,该综述旨在总结近十年来TMEM16A在肿瘤中的研究进展,为以后TMEM16A在肿瘤中的进一步研究提供新的思路。展开更多
目的探讨跨膜蛋白16A(transmembrane protein 16A,TMEM16A)在不同鼠龄豚鼠耳蜗血管纹上的表达及其与年龄相关性听力下降之间的关系。方法将健康豚鼠按照年龄分为:2周组、3月组、1年组、D-半乳糖(D-galactose,D-gal)衰老模型组;听性脑干...目的探讨跨膜蛋白16A(transmembrane protein 16A,TMEM16A)在不同鼠龄豚鼠耳蜗血管纹上的表达及其与年龄相关性听力下降之间的关系。方法将健康豚鼠按照年龄分为:2周组、3月组、1年组、D-半乳糖(D-galactose,D-gal)衰老模型组;听性脑干反应(auditory brainstem response,ABR)检测不同鼠龄豚鼠的听力变化;免疫荧光技术和免疫印迹实验(Western blot)检测TMEM16A在不同鼠龄豚鼠耳蜗血管纹中的分布和表达改变。结果 ABR反应阈值随鼠龄增长呈逐渐增高趋势,D-gal组与其他3组之间的差异具有统计学意义(P<0.01)。TMEM16A在不同鼠龄豚鼠耳蜗血管纹中均有表达,且表达量从2周组到1年组随鼠龄的增加呈上升趋势(P均<0.05);D-gal组表达量减少,与3月组和1年组均有统计学意义(P<0.05)。结论 TMEM16A在豚鼠耳蜗血管纹表达的变化可能与年龄相关性听力下降相关。展开更多
OBJECTIVE The Ca2+-activated Cl-channel(Ca CC)plays a crucial role in various physiological functions.Recent evidences suggest TMEM16A encodes CaC C in various cells,including endothelial cells.However,the role of TME...OBJECTIVE The Ca2+-activated Cl-channel(Ca CC)plays a crucial role in various physiological functions.Recent evidences suggest TMEM16A encodes CaC C in various cells,including endothelial cells.However,the role of TMEM16A in the vascular endothelial dysfunction in hypertension is unclear.METHODS In the study,RT-PCR,Western blotting,co-immunopricipitation,confocal imaging,patch-clamp,and endothelial-specific TMEM16A transgenic and knockout mice were employed.RESULTS We found that TMEM16A was expressed abundantly and functioned as Ca CC in endothelial cells.AngiotensinⅡ(AngⅡ)induced endothelial dysfunction with an increase in TMEM16A expression,which was alleviated by TMEM16A inhibitor.Further studies revealed that TMEM16A endothelial-specific knockout significantly lowered the blood pressure and ameliorated endothelial dysfunction in AngⅡ-induced hypertension,whereas,TMEM16A endothelial-specific overexpression showed the opposite effects.These results were related to the increased reactive oxygen species(ROS)generation,NADPH oxidase activation,and Nox2,p22phox expression facilitated by TMEM16A upon AngⅡ-induced hypertensive challenges.Moreover,TMEM16A directly interacted with Nox2 monomer and reduced the degradation of Nox2 through the proteasome-dependent endoplasmic recticulum-associated degradation pathway.TMEM16A also potentiated the translocation of p47phox and p67phox from cytosol to cell membrane and the subsequent interaction with Nox2.CONCLUSION Our results demonstrated that TMEM16A,as Ca CC,is a positive regulator of ROS generation via upregulating the activation of Nox2 NADPH oxidase in the vascular endothelium,and therefore facilitates endothelial dysfunction and hypertension.Modification of TMEM16A may be a novel therapeutic strategy for endothelial dysfunction-associated cardiovascular diseases.展开更多
文摘钙激活氯通道(calcium-activated chloride channels,CaCCs)是一类在多种细胞中广泛表达的氯离子通道,介导一系列重要的生理功能。TMEM16A(transmembrane protein 16A)于2008年被确认为CaCCs的分子身份之一。TMEM16A在多种病理生理过程中发挥重要的作用,如卵母细胞多重受精、分泌上皮细胞的液体分泌、平滑肌收缩、神经元兴奋、膜电位调节、感官信号传导以及肿瘤的发生和细胞迁移。近年来,TMEM16A在病理生理学中的作用及其在疾病治疗中的药靶地位受到高度重视。本文对TMEM16A研究的最新进展进行综述。
文摘跨膜蛋白16A(transmembrane protein 16A,TMEM16A)是一种钙激活的氯离子通道(calcium-activated chloride channel,CaCC),它在肿瘤中广泛过表达,对肿瘤的发生发展有着重要的影响。在各种肿瘤中,TMEM16A的过表达不仅可以促进癌细胞的增殖、转移和侵袭,抑制肿瘤细胞的凋亡,影响肿瘤的生长,还与肿瘤的治疗耐药、复发和预后不良有关。因此,探索TMEM16A的体内表达情况与肿瘤各个方面的关系具有重要的意义,该综述旨在总结近十年来TMEM16A在肿瘤中的研究进展,为以后TMEM16A在肿瘤中的进一步研究提供新的思路。
基金The project supported by National Natural Science Foundation of China(81230082,81302771,81525025,81573422,81500226)Natural Science Foundation of Guangdong Province(2014A030313087)by Science and Technology program of Guangzhou City(201607010255)
文摘OBJECTIVE The Ca2+-activated Cl-channel(Ca CC)plays a crucial role in various physiological functions.Recent evidences suggest TMEM16A encodes CaC C in various cells,including endothelial cells.However,the role of TMEM16A in the vascular endothelial dysfunction in hypertension is unclear.METHODS In the study,RT-PCR,Western blotting,co-immunopricipitation,confocal imaging,patch-clamp,and endothelial-specific TMEM16A transgenic and knockout mice were employed.RESULTS We found that TMEM16A was expressed abundantly and functioned as Ca CC in endothelial cells.AngiotensinⅡ(AngⅡ)induced endothelial dysfunction with an increase in TMEM16A expression,which was alleviated by TMEM16A inhibitor.Further studies revealed that TMEM16A endothelial-specific knockout significantly lowered the blood pressure and ameliorated endothelial dysfunction in AngⅡ-induced hypertension,whereas,TMEM16A endothelial-specific overexpression showed the opposite effects.These results were related to the increased reactive oxygen species(ROS)generation,NADPH oxidase activation,and Nox2,p22phox expression facilitated by TMEM16A upon AngⅡ-induced hypertensive challenges.Moreover,TMEM16A directly interacted with Nox2 monomer and reduced the degradation of Nox2 through the proteasome-dependent endoplasmic recticulum-associated degradation pathway.TMEM16A also potentiated the translocation of p47phox and p67phox from cytosol to cell membrane and the subsequent interaction with Nox2.CONCLUSION Our results demonstrated that TMEM16A,as Ca CC,is a positive regulator of ROS generation via upregulating the activation of Nox2 NADPH oxidase in the vascular endothelium,and therefore facilitates endothelial dysfunction and hypertension.Modification of TMEM16A may be a novel therapeutic strategy for endothelial dysfunction-associated cardiovascular diseases.
